Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    17-October-2000      
Issue 187 Next Update - 14:00 UTC 08:00 EST    18-October-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 17-October-2000:

Scientists at the National Institute on Drug Abuse (NIDA) have demonstrated that laboratory animals will self-administer marijuana's psychoactive component, THC (delta-9-tetrahydrocannabinol), in doses equivalent to those used by humans who smoke the drug. Self-administration of drugs by animals, long considered a model of human drug-seeking behavior, is characteristic of virtually all addictive and abused drugs.

In a companion piece, this Vidyya contains an informative guide on marijuana for parents. The guide is from the National Institute on Drug Abuse and can be freely copied and distributed.

In other news, over the past 14 months, AIDS treatment activists, many of whom are members of The HIV Immune Based Therapy Working Group have placed pressure on the Food and Drug Administration regarding the FDA process, procedures and review of immune based therapies for the treatment of HIV disease. In a surprise turn of events by the FDA Antiviral Committee, a meeting took place yesterday to discuss these issues.

In research news, scientists will be better able to fight Burkitt's lymphoma, a rare but deadly cancer that attacks children and AIDS patients, now that they have achieved a decades-long goal of genetically engineering mice to develop the disease.

Also on the subject of lymphoma, you can catch up on a month's reading in one place with abstracts from the last 30 days, all of which focus on the therapy of Non-Hodgkin's lymphoma. Topics cover salvage therapy, new clinical trial results and more.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.